Skye Bioscience SKYE
NASDAQ SKYE
$1.60 -0.01 (-0.62%)
As of: Oct 1, 2026 · 3:59 PM EDT

Skye Bioscience (SKYE) Change in Taxes (2013)

Updated

Skye Bioscience's Change in Taxes came in at -$796.00 for Q3 2013.

Analysis

Skye Bioscience (SKYE) Change in Taxes (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.22 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -1.53 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -131.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 171.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Skye Bioscience 7.07 Mn 7.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2013 -796.00
API Access

Skye Bioscience Change in Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-taxes&ticker=SKYE&period=max&api_key=YOUR_API_KEY